Victoza Type 2 Diabetes Injection Approved By EU
Posted in Diabetes News on 30. Jul, 2009
This month the EU (European Union) have given Novo Nordisk approval to market their latest Diabetes Management tool for persons with Diabetes throughout all the 27 member states. Victoza® is the brand name approved in Europe for liraglutide, the first once-daily human Glucagon-Like Peptide-1 (GLP-1) analogue developed for the treatment of type 2 diabetes. The [...]
